Medical Device News Magazine brings you up-to-date information on the newest medical device clinical trials, cutting-edge research studies, emerging data, and significant developments shaping the medical device and healthcare industries. With comprehensive coverage and expert analysis, the magazine highlights key findings, regulatory milestones, technological advancements, and scientific breakthroughs that influence patient care, clinical practice, and industry innovation. Whether you’re a clinician, researcher, or industry professional, it provides the timely insights you need to stay informed in an ever-evolving field.
Phase 3 Study of MR-139 for Blepharitis Update Provided by Viatris
The MR-139 3001 Phase 3 trial consisted of a randomized, placebo-controlled, double-masked prospective study, with a total of 477 patients who were randomized to receive either MR-139 or placebo, self-administered to the eyelids twice daily, treated and observed over 12 weeks.